Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-UCHL1 Antibody (R1M34)

Catalog #:   RHC44501 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IHC, IP, WB
Accession: P09936
Overview

Catalog No.

RHC44501

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Applications

IF, IHC, IP, WB

Recommended Dilution

Application Dilution
IF 1:50-1:200, IHC: 1:50-1:100, IP: 1:20, WB: 1:500-1:1000

Target

UCH-L1, PGP 9.5, UCHL1, Ubiquitin carboxyl-terminal hydrolase isozyme L1, Ubiquitin thioesterase L1, Neuron cytoplasmic protein 9.5, PGP9.5

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P09936

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1M34

Note

For research use only.

Data Image
  • Western blot
    Western blot analysis of PGP9.5 in 293, SH-SY5Y, mouse brain lysates using PGP9.5 antibody.
  • Western blot
    Western blot analysis of PGP9.5 in rat Brain lysates using PGP9.5 antibody.
References

Protein gene product 9.5 (PGP9.5) expression in benign cutaneous mesenchymal, histiocytic, and melanocytic lesions: comparison with cellular neurothekeoma., PMID:27914685

Characterization of smooth muscle, enteric nerve, interstitial cells of Cajal, and fibroblast-like cells in the gastric musculature of patients with diabetes mellitus., PMID:28028361

UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?, PMID:28116572

Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain., PMID:28326938

Activation of hepatic stellate cells by the ubiquitin C-terminal hydrolase 1 protein secreted from hepatitis C virus-infected hepatocytes., PMID:28667290

[The clinical significance of anti- ubiquitin C-terminal hydrolase L1 autoantibodies in the diagnosis of neuropsychiatric systemic lupus erythematosus]., PMID:29141377

Inflammatory Renin-Angiotensin System Disruption Attenuates Sensory Hyperinnervation and Mechanical Hypersensitivity in a Rat Model of Provoked Vestibulodynia., PMID:29155208

Alarmins in Frozen Shoulder: A Molecular Association Between Inflammation and Pain., PMID:29190116

Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice., PMID:29307588

Co-expression of vasoactive intestinal peptide and protein gene product 9.5 surrounding the lumen of human Schlemm's canal., PMID:29432726

Recovery of the sub-basal nerve plexus and superficial nerve terminals after corneal epithelial injury in mice., PMID:29550279

Ubiquitin-dependent proteolysis of CXCL7 leads to posterior longitudinal ligament ossification., PMID:29782494

Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy., PMID:30037345

Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain., PMID:30152246

The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus., PMID:30418114

Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral nerve regeneration., PMID:30531158

Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer., PMID:30537104

A20 overexpression exerts protective effects on podocyte injury in lupus nephritis by downregulating UCH-L1., PMID:30805933

Semaphorin 3A Inhibits Nerve Regeneration During Early Stage after Inferior Alveolar Nerve Transection., PMID:30862799

GDNF family receptor alpha 1 is a reliable marker of undifferentiated germ cells in bulls., PMID:31029848

Remodeling of Substance P Sensory Nerves and Transient Receptor Potential Melastatin 8 (TRPM8) Cold Receptors After Corneal Experimental Surgery., PMID:31157834

Histological Corneal Alterations in Keratoconus After Crosslinking-Expansion of Findings., PMID:31513045

Single-step functionalization of poly-catecholamine nanofilms for ultra-sensitive immunosensing of ubiquitin carboxyl terminal hydrolase-L1 (UCHL-1) in spinal cord injury., PMID:31561093

Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice., PMID:31811410

Abolishing UCHL1's hydrolase activity exacerbates TBI-induced axonal injury and neuronal death in mice., PMID:33159930

Impact of prostatic radiation therapy on bladder contractility and innervation., PMID:34015163

Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2W., PMID:34326324

Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19., PMID:34504487

Utility of autoantibody against an UCH-L1 epitope as a serum diagnostic marker for neuropsychiatric systemic lupus erythematosus., PMID:35084329

Development of an electrochemical impedance spectroscopy based biosensor for detection of ubiquitin C-Terminal hydrolase L1., PMID:35390718

Label-free, ultrasensitive and rapid detection of FDA-approved TBI specific UCHL1 biomarker in plasma using MWCNT-PPY nanocomposite as bio-electrical transducer: A step closer to point-of-care diagnosis of TBI., PMID:35973277

[Clinical significance of autoantibodies against ubiquitin carboxyl hydrolase L1 epitopes in the screening and diagnosis of Sjögren syndrome]., PMID:36058683

Morphometric and immunohistochemical analysis as a method to identify undifferentiated spermatogonial cells in adult subjects with Klinefelter syndrome: a cohort study., PMID:36116982

Development of a novel bioengineered 3D brain-like tissue for studying primary blast-induced traumatic brain injury., PMID:36200530

A cross-sectional study of antibodies to ubiquitin proteasome system in different glomerulopathies., PMID:36472403

Decipher potential biomarkers of diagnosis and disease activity for NMOSD with AQP4 using LC-MS/MS and Simoa., PMID:36709595

Qixue Shuangbu decoction and acupuncture combined with Western medicine in acute severe stroke patients., PMID:36793635

Drug repurposing screens identify compounds that inhibit α-synuclein oligomers' membrane disruption and block antibody interactions., PMID:36937574

Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress., PMID:36952018

Transcriptome sequencing reveals novel molecular features of SLE severity., PMID:37554401

Review of the Role of Rituximab in the Management of Adult Minimal Change Disease and Immune-Mediated Focal and Segmental Glomerulosclerosis., PMID:37901702

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder., PMID:38134369

Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses., PMID:38135686

A study of PGP 9.5 immunohistochemical labeling on formalin-fixed paraffin embedded tissues for epidermal nerve fiber density testing., PMID:39287221

PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entities., PMID:39520970

A Novel IgG-IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules., PMID:39661479

Effect of Anti-TNF Monoclonal Antibody on Enteric Neurons and Enteric Glial Cells in Experimental Colitis., PMID:39946069

Epidermal Transient Receptor Potential Vanilloid 1 innervation is increased in patients with painful diabetic polyneuropathy experiencing ongoing burning pain., PMID:39968935

Inhibition of UCH-L1 enhances immunotherapy efficacy in triple-negative breast cancer by stabilizing PD-L1., PMID:40389130

Association of neurobiological and immune serum biomarkers with Toxoplasma gondii infection in patients with schizophrenia., PMID:40397143

Datasheet

Document Download

Anti-UCHL1 Antibody (R1M34).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-UCHL1 Antibody (R1M34) [RHC44501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only